打开阅读框
翻译(生物学)
上游开放阅读框
阅读(过程)
帧(网络)
上游(联网)
介绍(产科)
肽
计算机科学
癌症研究
生物
医学
语言学
信使核糖核酸
肽序列
遗传学
电信
基因
生物化学
哲学
放射科
作者
Alexander Kowar,Jonas P. Becker,Rossella Del Pizzo,Zhiwei Tang,Julien Champagne,Pierre-René Körner,Jasmine Montenegro Navarro,Fiona Megan Tilghman,Hanan Sakeer,Angelika B. Riemer,Reuven Agami,Fabricio Loayza‐Puch
出处
期刊:
[Cold Spring Harbor Laboratory]
日期:2025-01-09
标识
DOI:10.1101/2025.01.08.631915
摘要
Abstract Mitosis is a critical phase of the cell cycle and a vulnerable point where cancer cells can be effectively disrupted, leading to cell death and inhibition of tumor growth. However, challenges such as drug resistance remain significant in clinical applications. During mitosis, mRNA translation is generally downregulated, while non-canonical translation of specific transcripts proceeds. Here, we demonstrate that mitotic cancer cells redistribute ribosomes toward the 5’ untranslated region (5’ UTR) and the start of the coding sequence (CDS), enhancing the translation of thousands of upstream open reading frames (uORFs) and upstream overlapping open reading frames (uoORFs). This mitotic induction of uORF/uoORF enriches the presentation of immunopeptides at the surface of cancer cells following treatment with mitotic inhibitors. Functional assays indicate the potential of such neoepitopes to provoke cancer-cell killing by T cells. Altogether, our findings highlight the therapeutic potential of targeting uORF/uoORF-derived neoepitopes in combination with mitotic inhibitors to enhance immune recognition and tumor cell elimination.
科研通智能强力驱动
Strongly Powered by AbleSci AI